Whole-Genome Sequencing Dataset from Two High-Risk Breast Cancer Families Negative for BRCA1/2 and Other Known Susceptibility Genes

Hereditary breast cancer (BC) remains unexplained in a substantial proportion of families who test negative for BRCA1/2 and other known susceptibility genes. To contribute to the genomic characterization of these unresolved cases, we generated a whole-genome sequencing (WGS) dataset from six women belonging to two unrelated high-risk families, each comprising three sisters diagnosed with BC. All participants had previously received negative results in conventional multigene panel testing. WGS was performed on peripheral blood DNA using the Illumina NovaSeq platform, followed by variant calling against GRCh38 and the comprehensive annotation of single-nucleotide variants, indels, and structural variants. For each family, we identified shared ClinVar-annotated variants, rare exonic or splice-site alterations, and intronic variants located within a curated set of 286 cancer-related genes. The dataset includes per-patient VCF files, copy number variation annotations, and family-level variant summaries. Raw and processed data are publicly available through the Sequence Read Archive and Zenodo. This resource supports variant reinterpretation, exploration of regulatory and intronic regions, and methodological benchmarking in the study of familial BC beyond established susceptibility genes.

Authors

Institutions

Publication Details

Journal
Data
Published
2026-04-30
DOI
https://doi.org/10.3390/data11050099
Primary Topic
BRCA gene mutations in cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Whole-Genome Sequencing Dataset from Two High-Risk Breast Cancer Families Negative for BRCA1/2 and Other Known Susceptibility Genes

Laia Garrigós, José Manuel Pérez-García, José Palacios, Sandra Iñiguez‐Muñoz et al.
Data
BRCA gene mutations in cancer
article

Whole-Genome Sequencing Dataset from Two High-Risk Breast Cancer Families Negative for BRCA1/2 and Other Known Susceptibility Genes

Laia Garrigós, José Manuel Pérez-García, José Palacios, Sandra Iñiguez‐Muñoz, Silvia González-Martínez, Javier Román, Javier Cortés, Alejandra Rezqallah Arón, Daniela Camacho, Diego M. Marzese, Belén Pérez-Mies, Judith Balmaña
article en

Abstract

Hereditary breast cancer (BC) remains unexplained in a substantial proportion of families who test negative for BRCA1/2 and other known susceptibility genes. To contribute to the genomic characterization of these unresolved cases, we generated a whole-genome sequencing (WGS) dataset from six women belonging to two unrelated high-risk families, each comprising three sisters diagnosed with BC. All participants had previously received negative results in conventional multigene panel testing. WGS was performed on peripheral blood DNA using the Illumina NovaSeq platform, followed by variant calling against GRCh38 and the comprehensive annotation of single-nucleotide variants, indels, and structural variants. For each family, we identified shared ClinVar-annotated variants, rare exonic or splice-site alterations, and intronic variants located within a curated set of 286 cancer-related genes. The dataset includes per-patient VCF files, copy number variation annotations, and family-level variant summaries. Raw and processed data are publicly available through the Sequence Read Archive and Zenodo. This resource supports variant reinterpretation, exploration of regulatory and intronic regions, and methodological benchmarking in the study of familial BC beyond established susceptibility genes.

DataVol. 11(5)
Hebron University (PS), Duke University (US), Universidad de Alcalá (ES), Instituto Cajal (ES), Instituto de Salud Carlos III (ES), Hospital Universitario de Torrejón (ES), Asociación Española Contra el Cáncer (ES), MedSIR (Spain) (ES), Hospital Infantil Universitario Niño Jesús (ES), Health Research Institute of the Balearic Islands (ES), Instituto Ramón y Cajal de Investigación Sanitaria (ES), International Breast Cancer Study Group (CH), Centro de Investigación Biomédica en Red de Cáncer (ES), Universidad Europea de Madrid (ES)
Good health and well-being
Openalex Percentile: Top 9%
BRCA gene mutations in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.